Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Autolus Therapeutics (AUTL) Return on Equity (2018 - 2025)

Autolus Therapeutics' Return on Equity history spans 8 years, with the latest figure at 1.3% for Q4 2025.

  • For Q4 2025, Return on Equity fell 81.0% year-over-year to 1.3%; the TTM value through Dec 2025 reached 1.3%, down 81.0%, while the annual FY2025 figure was 0.95%, 13.0% down from the prior year.
  • Return on Equity reached 1.3% in Q4 2025 per AUTL's latest filing, down from 0.73% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.08% in Q4 2021 to a low of 1.43% in Q4 2023.
  • Average Return on Equity over 5 years is 0.62%, with a median of 0.63% recorded in 2023.
  • Peak YoY movement for Return on Equity: skyrocketed 94bps in 2024, then tumbled -81bps in 2025.
  • A 5-year view of Return on Equity shows it stood at 0.08% in 2021, then tumbled by -721bps to 0.65% in 2022, then plummeted by -120bps to 1.43% in 2023, then skyrocketed by 66bps to 0.49% in 2024, then crashed by -166bps to 1.3% in 2025.
  • Per Business Quant, the three most recent readings for AUTL's Return on Equity are 1.3% (Q4 2025), 0.73% (Q3 2025), and 0.63% (Q2 2025).